Loading…
Symbiotec Pharmalab (SYMBIOTEC)₹1,555−2.70%Pharmaceuticals
Symbiotec Pharmalab is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 88.5 against a peer median of 40.2, and ROCE of 13.0% against a peer median of 18.0%, and latest-quarter sales growth of 7.5% against a peer median of 14.0%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sudeep Pharma | 13,676 | 72.4 | 27.9 | 25.2 | 0.17 | 0.1 | 641 | 174 | 20.7 | 10.6 | vs SYMBIOTEC |
| Concord Biotech | 12,533 | 44.3 | 17.0 | 12.5 | 0.00 | 0.6 | 1,052 | 258 | 25.2 | 11.0 | vs SYMBIOTEC |
| Akums Drugs and Pharmaceuticals | 12,024 | 41.2 | 15.0 | 8.5 | 0.05 | 0.1 | 4,347 | 255 | 14.0 | 55.5 | vs SYMBIOTEC |
| Viyash Scientific | 10,379 | 41.0 | 13.0 | 7.4 | 0.17 | 0.0 | 3,432 | 225 | 19.3 | 113.3 | vs SYMBIOTEC |
| Blue Jet Healthcare | 10,273 | 40.2 | 26.0 | 19.9 | 0.03 | 0.2 | 946 | 248 | −17.4 | −14.3 | vs SYMBIOTEC |
| Symbiotec Pharmalab | 9,997 | 88.5 | 13.0 | 11.7 | 0.34 | 0.0 | 867 | 110 | 7.5 | −53.3 | — |
| Procter & Gamble Health | 9,461 | 26.6 | 83.9 | 61.7 | 0.02 | 2.7 | 1,404 | 326 | 7.4 | 45.3 | vs SYMBIOTEC |
| Strides Pharma Science | 9,240 | 15.0 | 18.0 | 20.0 | 0.57 | 0.5 | 4,873 | 573 | 17.1 | 1.6 | vs SYMBIOTEC |
| Aarti Pharmalabs | 8,357 | 32.4 | 11.1 | 8.6 | 0.36 | 0.4 | 1,816 | 175 | 46.0 | 153.8 | vs SYMBIOTEC |
| Sanofi Consumer Healthcare India | 7,933 | 29.9 | 90.0 | 71.6 | 0.06 | 2.2 | 876 | 240 | 6.9 | 13.2 | vs SYMBIOTEC |
| Sanofi India | 7,657 | 23.6 | 58.1 | 43.0 | 0.02 | 3.7 | 1,842 | 327 | 7.9 | 19.9 | vs SYMBIOTEC |
| Peer median | 9,997 | 40.2 | 18.0 | 19.9 | 0.06 | 0.4 | 1,404 | 248 | 14.0 | 13.2 |
Listed companies closest to Symbiotec Pharmalab in Pharmaceuticals include Sudeep Pharma, Concord Biotech, Akums Drugs and Pharmaceuticals, Viyash Scientific, Blue Jet Healthcare, Procter & Gamble Health, Strides Pharma Science, Aarti Pharmalabs.
Sudeep Pharma, with a market cap of ₹13,676 Cr.
Symbiotec Pharmalab trades at a P/E of 88.5; the median of its peer set is 40.2. A P/E above or below the median is a description, not a judgement on value.
Symbiotec Pharmalab's return on capital employed is 13.0%, below the peer median of 18.0%.